L, F., VM, T., S, B., C, M., IP, G., G, Z., & E, D. (2026). Olipudase alfa IgE-mediated anaphylaxis prevented by omalizumab and tailored desensitization in a child with acid sphingomyelinase deficiency. Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 37(5), e70375. https://doi.org/10.1111/pai.70375
Chicago Style (17th ed.) CitationL, Fiori, Tagi VM, Beretta S, Montanari C, Greco IP, Zuccotti G, and D'Auria E. "Olipudase Alfa IgE-mediated Anaphylaxis Prevented by Omalizumab and Tailored Desensitization in a Child with Acid Sphingomyelinase Deficiency." Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology 37, no. 5 (2026): e70375. https://doi.org/10.1111/pai.70375.
MLA (9th ed.) CitationL, Fiori, et al. "Olipudase Alfa IgE-mediated Anaphylaxis Prevented by Omalizumab and Tailored Desensitization in a Child with Acid Sphingomyelinase Deficiency." Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology, vol. 37, no. 5, 2026, p. e70375, https://doi.org/10.1111/pai.70375.
